# ArriVent BioPharma, Inc.: Form SC 13D, filed Feb 5, 2024

- Company: [ArriVent BioPharma, Inc.](/companies/avbp.md) (CIK 1868279)
- Form: SC 13D
- Filed: 2024-02-05
- Accepted by EDGAR: Feb 5, 2024, 16:42 ET
- Period: not reported
- Accession: 0000947871-24-000091
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1868279/000094787124000091/ss2992197_sc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1868279/000094787124000091/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1868279/000094787124000091/ss2992197_sc13d.htm

Filed Feb 5, 2024.
Source: SEC EDGAR, the filing index for accession 0000947871-24-000091. Last ingested by Listed: Nov 10, 2026, 02:46 ET. No prices; not investment advice.